MARKET

DARE

DARE

Dare Bioscience
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8456
-0.0240
-2.76%
Closed 16:00 09/18 EDT
OPEN
0.8294
PREV CLOSE
0.8696
HIGH
0.8958
LOW
0.8201
VOLUME
73.15K
TURNOVER
--
52 WEEK HIGH
3.250
52 WEEK LOW
0.6000
MARKET CAP
14.11M
P/E (TTM)
-0.8114
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of DARE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

DARE News

  • Edited Transcript of DARE earnings conference call or presentation 14-Aug-19 8:30pm GMT
  • Thomson Reuters StreetEvents.5d ago
  • Daré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-VVA1, a Novel Application of Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy, in the International Journal of Pharmaceutics
  • GlobeNewswire.09/11 13:00
  • Could The Daré Bioscience, Inc. (NASDAQ:DARE) Ownership Structure Tell Us Something Useful?
  • Simply Wall St..09/09 17:13
  • Daré Bioscience Announces Completion of its Content Validity Study to Support the Continued Clinical Development of Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
  • GlobeNewswire.09/09 12:00

More

Industry

Biotechnology & Medical Research
-0.68%
Pharmaceuticals & Medical Research
-0.14%

Hot Stocks

Name
Price
%Change

About DARE

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
More

Webull offers Dare Bioscience Inc (DARE) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.